HHLR Advisors’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

HHLR Advisors’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,062,383	Closed	-$66M	–	69
2023 Q4	$66M	Sell	1,062,383 -333,333	-24%	-$8.29M	1.33%	12
2023 Q3	$31M	Buy	+1,395,716	New	+$29.3M	0.69%	20

HHLR Advisors's RYZB Position: Q1 2024 in Review

HHLR Advisors sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 1,062,383 shares — an estimated $66M sold.

HHLR Advisors first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $66M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

HHLR Advisors reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
HHLR Advisors sold 1,062,383 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $66M.
HHLR Advisors first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
HHLR Advisors's RayzeBio, Inc. Common Stock position peaked at $66M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on HHLR Advisors's 13F filing for Q1 2024, filed 14 May 2024.